Libuse Latalova - CEZ A Head Admin
Insider
Libuse Latalova is Head Admin of CEZ A S
| Phone | 420 2 1104 1111 |
| Web | https://www.cez.cz |
CEZ A Management Efficiency
The company has return on total asset (ROA) of 0.0306 % which means that it generated a profit of $0.0306 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4104 %, meaning that it generated $0.4104 on every $100 dollars invested by stockholders. CEZ A's management efficiency ratios could be used to measure how well CEZ A manages its routine affairs as well as how well it operates its assets and liabilities.CEZ A S has accumulated 95.92 B in total debt with debt to equity ratio (D/E) of 1.24, which is about average as compared to similar companies. CEZ A S has a current ratio of 0.93, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist CEZ A until it has trouble settling it off, either with new capital or with free cash flow. So, CEZ A's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CEZ A S sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CEZ to invest in growth at high rates of return. When we think about CEZ A's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| CFP CFP | Futuretech II Acquisition | 61 | |
| Michael Ackermann | Tarsus Pharmaceuticals | 42 | |
| Yuquan Wang | Futuretech II Acquisition | 52 | |
| Ryan Richardson | BioNTech SE | 46 | |
| M MD | Lipocine | 66 | |
| Bobak MD | Tarsus Pharmaceuticals | N/A | |
| Jens Holstein | BioNTech SE | 62 | |
| Krista Fogarty | Lipocine | 57 | |
| Elizabeth MD | Tarsus Pharmaceuticals | 47 | |
| Ozlem MD | BioNTech SE | 58 | |
| Sierk Poetting | BioNTech SE | 52 | |
| Logan Morse | Lipocine | 55 | |
| Leonard JD | Tarsus Pharmaceuticals | 48 | |
| Michael Boehler | BioNTech SE | N/A | |
| CPA CPA | Lipocine | 54 | |
| Dianne MSW | Tarsus Pharmaceuticals | 47 | |
| David Nakasone | Tarsus Pharmaceuticals | N/A | |
| BS CPA | Inhibrx | 42 | |
| Mark Lappe | Inhibrx | 58 | |
| Quinn Deveraux | Inhibrx | N/A | |
| Seshadri Neervannan | Tarsus Pharmaceuticals | 56 | |
Management Performance
| Return On Equity | 0.41 | |||
| Return On Asset | 0.0306 |
CEZ A S Leadership Team
Elected by the shareholders, the CEZ A's board of directors comprises two types of representatives: CEZ A inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CEZ. The board's role is to monitor CEZ A's management team and ensure that shareholders' interests are well served. CEZ A's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CEZ A's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ju MBA, Chief Director | ||
| Barbara Seidlova, Head of Investor Relations | ||
| Engineer MBA, Chairman CEO | ||
| Engineer Cyrani, Deputy Chairman | ||
| Bohdana Horackova, New Director | ||
| Radim Sladkovsk, Director Section | ||
| Libuse Latalova, Head Admin | ||
| Tomas MBA, Chief Energy | ||
| Juraj Szab, Director Section |
CEZ Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CEZ A a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.41 | |||
| Return On Asset | 0.0306 | |||
| Profit Margin | 0.20 % | |||
| Current Valuation | 23.51 B | |||
| Shares Outstanding | 536.79 M | |||
| Shares Owned By Insiders | 69.70 % | |||
| Shares Owned By Institutions | 4.20 % | |||
| Price To Earning | 13.58 X | |||
| Price To Book | 4.57 X | |||
| Price To Sales | 1.15 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Consideration for investing in CEZ Pink Sheet
If you are still planning to invest in CEZ A S check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CEZ A's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |